Drug Co. Lays Off Hundreds More Workers

By Eric S. Page
|  Tuesday, May 5, 2009  |  Updated 10:31 AM PDT
View Comments (
)
|
Email
|
Print
Drug Co. Lays Off Hundreds More Workers

Getty Images/John-Francis Bourke

Amylin cut its San Diego workforce by 25 percent in November 2008. About 340 employees were laid off.

advertisement

A local company that laid off hundreds of workers last year sharpened its budget knife again.

Meanwhile, San Diego-based Amylin Pharmaceuticals Inc. is cutting about 200 jobs, or more than a third of its sales force, as it combines primary care and specialty drug sales units.

In other news, the biotechnology company Amylin Pharmaceuticals applied for Food and Drug Administration approval of its once-weekly diabetes treatment. The drug candidate exenatide LAR, an extended version of the twice-daily injectable drug Byetta, is being viewed by Wall Street as a way for Amylin to reinvigorate sales. The drug's competition would likely include Novo Nordisk's once-daily treatment Liraglutide, which is currently under FDA review.
 

Get the latest headlines sent to your inbox!
View Comments (
)
|
Email
|
Print
Leave Comments
Follow Us
Sign up to receive news and updates that matter to you.
Send Us Your Story Tips
Check Out